Cibc World Markets Corp Ligand Pharmaceuticals Inc Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 3,974 shares of LGND stock, worth $581,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,974Holding current value
$581,475% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding LGND
# of Institutions
286Shares Held
18.9MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$420 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$301 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$150 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$133 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$109 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.47B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...